Research Learning Series (RLS) - Industry Funded Research

The SAEM Research Directors Interest Group and the SAEM Research Committee presented information on the pros and cons of industry-sponsored research, how to secure industry funding, and tips for a successful partnership with industry. By the end of this presentation, participants will be able to:

  • Understand the rationale and benefits of engaging in industry-sponsored research.
  • Identify key steps in developing a research infrastructure.
  • Recognize ethical, regulatory, and operational considerations.
  • Learn strategies to initiate, sustain, and scale collaborations with industry.
Authors

  • R. Gentry Wilkerson, MD

    Director of Clinical Research

    University of Maryland School of Medicine

    R. Gentry Wilkerson, MD, is the Director of Clinical Research and Assistant Residency Program Director at the University of Maryland School of Medicine (UMSOM), Department of Emergency Medicine. He also serves as the clinical leader of the University of Maryland Medical Center (UMMC) Multidisciplinary Adult Sickle Cell Disease Program. He is the co-chair of the UMMC Opioid Safety Council and chair of the Maryland state chapter of the Naloxone Project, a nonprofit that works to increase distribution of naloxone. He is the Deputy Editor of the Clinical Practice and Cases in Emergency Medicine journal. In 2015, Dr. Wilkerson received the Outstanding Teacher Award from the UMEM Residency Program. In 2016, he was chosen as a National Foundation Emergency Medicine (NFEM) Scholar. He was awarded Clinician of the Year in 2019 by the Maryland chapter of the American College of Emergency Physicians (ACEP). In 2021, he was named an NFEM Mentor, and he now serves as the Director of the Mentor-Scholars Program for NFEM. Dr. Wilkerson's research focuses on improving access to new diagnostic tools and therapeutic agents for emergent medical conditions.

Related Media